News & Events
16 May 2022
7th Consortium Meeting in Stockholm
On the 9th & 10th of May we met in Stockholm for the 7th PREFERABLE Consortium Meeting.
6 April 2022
Over 300 participants in EFFECT trial
This week we reached a number of over 300 participants in the EFFECT trial. In total we aim for 350 participants, which we expect to reach this summer.
2 November 2021
200th participant included!
We have now included our 200th participant in the EFFECT trial!

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.